Menu
Back to User profile » Prof. Dr. Nicola Scichilone
Papers published by Prof. Dr. Nicola Scichilone:
Exacerbation Burden in COPD and Occurrence of Mortality in a Cohort of Italian Patients: Results of the Gulp Study
Santus P, Di Marco F, Braido F, Contoli M, Corsico AG, Micheletto C, Pelaia G, Radovanovic D, Rogliani P, Saderi L, Scichilone N, Tanzi S, Vella M, Boarino S, Sotgiu G, Solidoro P
International Journal of Chronic Obstructive Pulmonary Disease 2024, 19:607-618
Published Date: 1 March 2024
Clinical Evolution and Quality of Life in Clinically Based COPD Chronic Bronchitic and Emphysematous Phenotypes: Results from the 1-Year Follow-Up of the STORICO Italian Observational Study
Blasi F, Antonelli Incalzi R, Canonica GW, Schino P, Cuttitta G, Zullo A, Ori A, Scichilone N
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:2133-2148
Published Date: 21 July 2021
Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program
Campisi R, Crimi C, Nolasco S, Beghè B, Antonicelli L, Guarnieri G, Scichilone N, Porto M, Macchia L, Scioscia G, Foschino Barbaro MP, Papi A, Crimi N
Journal of Asthma and Allergy 2021, 14:575-583
Published Date: 27 May 2021
Overcoming Barriers to the Effective Management of Severe Asthma in Italy
Paggiaro P, Barbaglia S, Centanni S, Croce D, Desideri E, Giustini S, Micheletto C, Musarra A, Scichilone N, Trama U, Zedda MT, Canonica GW
Journal of Asthma and Allergy 2021, 14:481-491
Published Date: 10 May 2021
One-Year Evolution of Symptoms and Health Status of the COPD Multi-Dimensional Phenotypes: Results from the Follow-Up of the STORICO Observational Study
Incalzi RA, Blasi F, Scichilone N, Zullo A, Simoni L, Canonica GW
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1007-1020
Published Date: 20 April 2021
Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression
Pelaia C, Crimi C, Benfante A, Caiaffa MF, Calabrese C, Carpagnano GE, Ciotta Jnr D, D'Amato M, Macchia L, Nolasco S, Pelaia G, Pellegrino S, Scichilone N, Scioscia G, Spadaro G, Valenti G, Vatrella A, Crimi N
Journal of Asthma and Allergy 2021, 14:163-173
Published Date: 22 February 2021
Airway Deposition of Extrafine Inhaled Triple Therapy in Patients with COPD: A Model Approach Based on Functional Respiratory Imaging Computer Simulations
Usmani OS, Scichilone N, Mignot B, Belmans D, Van Holsbeke C, De Backer J, De Maria R, Cuoghi E, Topole E, Georges G
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2433-2440
Published Date: 7 October 2020
Day and Night Control of COPD and Role of Pharmacotherapy: A Review
Braghiroli A, Braido F, Piraino A, Rogliani P, Santus P, Scichilone N
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:1269-1285
Published Date: 4 June 2020
Early management of COPD: where are we now and where do we go from here? A Delphi consensus project
Di Marco F, Balbo P, de Blasio F, Cardaci V, Crimi N, Girbino G, Pelaia G, Pirina P, Roversi P, Santus P, Scichilone N, Vatrella A, Pasqualetti P, Carone M
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:353-360
Published Date: 4 February 2019
Disease awareness in patients with COPD: measurement and extent
Baiardini I, Rogliani P, Santus P, Corsico AG, Contoli M, Scichilone N, Di Marco F, Lessi P, Scognamillo C, Molinengo G, Ferri F, Patella V, Fiorentino G, Carone M, Braido F
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:1-11
Published Date: 17 December 2018
LABA/LAMA fixed-dose combinations in patients with COPD: a systematic review
Rogliani P, Calzetta L, Braido F, Cazzola M, Clini E, Pelaia G, Rossi A, Scichilone N, Di Marco F
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3115-3130
Published Date: 4 October 2018
Impact of reslizumab on outcomes of severe asthmatic patients: current perspectives
Padilla Galo A, Labor M, Tiotiu A, Baiardini I, Scichilone N, Braido F
Patient Related Outcome Measures 2018, 9:267-273
Published Date: 17 August 2018
Effects of aclidinium on determinants of COPD severity: symptoms and quality of life
Contoli M, Solidoro P, Di Marco F, Scichilone N, Corsico A, Braido F, Santus P
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:3043-3050
Published Date: 5 December 2016
Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD
Scichilone N, Benfante A, Morandi L, Bellini F, Papi A
Patient Related Outcome Measures 2014, 5:153-162
Published Date: 27 November 2014
Safety and efficacy of montelukast as adjunctive therapy for treatment of asthma in elderly patients
Scichilone N, Battaglia S, Benfante A, Bellia V
Clinical Interventions in Aging 2013, 8:1329-1337
Published Date: 2 October 2013